I agree with the GHS paper, especially the reactivation of the GLE license, clearly that has to be at Wilmington because Paducah would require a separate license, but when you look at how GLE have been hiring PERMANENT positions at Wilmington, and the fact that GLE have applied for some of the IRA for HALEU production for the fuel bank (LEU+up to 10% is still HALEU) which needs the fuel next year, surely the license reinstatement has already been discussed with the DOE and NRC and is either underway or already been agreed to IMHO?
From the GHS Climate White Paper
However, as we will explain in Section 7, U.S. development of laser enrichment technology is essential to ensure that U.S. enrichment capacity remains competitive on the global market
From Section 7
Recommendation 2: Support further development and possible commercialization of laser enrichment technology.
As we previously discussed, the historical circumstances allowing the Soviet Union to surpass the United States gas centrifuge development during the Cold War allowed the US—and the rest of the world—to become highly dependent on Russia for uranium enrichment capacity.
If the U.S. is to avoid a similar error, the US must ensure that it remains on the technical cutting edge for uranium enrichment technology.
Laser enrichment offers tremendous promise but has yet to be commercially developed anywhere in the world.
In 2015, the US Nuclear Regulatory Commission granted Global Laser Enrichment (GLE) a license to build and operate a laser enrichment enrichment facility with 6 million SWU of
capacity.
Alas, this license was terminated at the request of GLE in January 2021.
The U.S. Department of Energy should explore policy options to facilitate commercialization of laser enrichment technology. Additionally, the NRC should clarify what steps would be required to reactivate the Global Laser Enrichment license.
Must be my rose colored glasses here by thinking this LOL!
- Forums
- ASX - By Stock
- Nuclear Power Related Media Thread
SLX
silex systems limited
Add to My Watchlist
2.25%
!
$4.34

I agree with the GHS paper, especially the reactivation of the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.34 |
Change
-0.100(2.25%) |
Mkt cap ! $1.033B |
Open | High | Low | Value | Volume |
$4.54 | $4.61 | $4.32 | $3.963M | 895.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16533 | $4.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 3059 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1162 | 4.310 |
1 | 338 | 4.260 |
1 | 1185 | 4.210 |
2 | 22090 | 4.200 |
1 | 1130 | 4.180 |
Price($) | Vol. | No. |
---|---|---|
4.410 | 28344 | 1 |
4.520 | 571 | 1 |
4.560 | 800 | 1 |
4.570 | 11982 | 1 |
4.580 | 25000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online